Evidence map

Observational studyVascular health and risk management2013

Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice.

Peter Bramlage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24039432